Literature DB >> 8817558

Identification of four splice variants of the mouse stress-activated protein kinase JNK/SAPK alpha-isoform.

E Casanova1, C Garate, S Ovalle, P Calvo, M A Chinchetru.   

Abstract

Four splice variants (alpha I-IV) of the stress-activated protein kinase JNK/SAPK alpha-isoform have been identified in the mouse. One of them (alpha I) contains an open reading frame of 1269 bp encoding a potential protein of 423 amino acids, whereas the second variant (alpha II) differs in a region encoding 31 amino acids located in subdomain IX. alpha III lacks this region and also differs in the terminal portion of the 3' untranslated region (3' UTR). A fourth variant (alpha IV) which lacks a region of 41 amino acids located in subdomain IX has also been identified. These splice variants are differentially expressed in mouse tissues: alpha I is the most abundant in brain areas, whereas alpha II is mainly expressed in extracerebral tissues, such as liver; alpha III and alpha IV are present in brain and other tissues although in lower amounts.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8817558     DOI: 10.1097/00001756-199605170-00021

Source DB:  PubMed          Journal:  Neuroreport        ISSN: 0959-4965            Impact factor:   1.837


  3 in total

1.  The expression changes of vacuolar protein sorting 4B (VPS4B) following middle cerebral artery occlusion (MCAO) in adult rats brain hippocampus.

Authors:  Gang Cui; Yunfeng Wang; Shanshan Yu; Lixiang Yang; Bing Li; Wei Wang; Peng Zhou; Jiang Wu; Ting Lu; Dongjian Chen
Journal:  Cell Mol Neurobiol       Date:  2014-01       Impact factor: 5.046

2.  Alternative splicing and bioinformatic analysis of human U12-type introns.

Authors:  Wen-Cheng Chang; Yung-Chia Chen; Kuo-Ming Lee; Woan-Yuh Tarn
Journal:  Nucleic Acids Res       Date:  2007-03-01       Impact factor: 16.971

3.  JNK1 is not essential for TNF-mediated joint disease.

Authors:  Marcus Köller; Silvia Hayer; Kurt Redlich; Romeo Ricci; Jean-Pierre David; Günter Steiner; Josef S Smolen; Erwin F Wagner; Georg Schett
Journal:  Arthritis Res Ther       Date:  2004-12-07       Impact factor: 5.156

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.